Income StatementBalance SheetCash FlowSegments
Bristol-Myers Squibb logo

Bristol-Myers Squibb Income Statement

Revenue, expenses, and profitability over time

Bristol-Myers Squibb generated $48.5B in trailing twelve-month revenue, up 0.0% year-over-year. Net income was $7.3B with a 15.01% net margin. Diluted EPS is $3.56, which grew 0.4% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$48.5BGross Profit (TTM)$34.2BNet Income (TTM)$7.3BEps Diluted (TTM)$3.56
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$121.42B
P/E Ratio16.69
ROE38.84%

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Basic earnings per share$0.00$1.21$0.64$1.08$0.54$1.31
Diluted earnings per share$0.00$1.20$0.64$1.08$0.53$1.31

Operating Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gross profit$7.5B$8.2B$8.9B$8.8B$8.4B$8.1B

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Other Charges-$305.0M-$339.0M-$494.0M$108.0M$0.0-$32.0M

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$0.0$3.0B$1.8B$3.1B$1.5B$3.2B

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$99.0M$509.0M$460.0M$919.0M$384.0M$561.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net income$0.0$2.5B$1.3B$2.2B$1.1B$2.7B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquired IPRD$30.0M$188.0M$1.5B$633.0M$1.4B$94.0M
Amortization of acquired intangible assets$1.7B$830.0M$830.0M$831.0M$826.0M$437.0M
Other income, net (Note 6)-$305.0M-$339.0M-$494.0M$108.0M$0.0-$32.0M

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Research and development$3.2B$2.3B$2.6B$2.5B$2.6B$2.6B
Selling, general and administrative$2.1B$1.6B$1.7B$1.8B$2.2B$1.6B
Total operating expenses$12.2B$8.2B$10.5B$9.1B$11.0B$8.3B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total cost of revenue$4.8B$3.0B$3.4B$3.4B$4.1B$3.4B

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Total revenue$12.3B$11.2B$12.3B$12.2B$12.5B$11.5B